Home
>
National Drug Code (NDC)
>
Lidocaine Hydrochloride and Epinephrine Bitartrate
Lidocaine Hydrochloride and Epinephrine Bitartrate - 51004-2010-5 - (Lidocaine Hydrochloride and Epinephrine Bitartrate)
Drug Information of Lidocaine Hydrochloride and Epinephrine Bitartrate
| Product NDC: | 51004-2010 |
| Proprietary Name: | Lidocaine Hydrochloride and Epinephrine Bitartrate |
| Non Proprietary Name: | Lidocaine Hydrochloride and Epinephrine Bitartrate |
| Active Ingredient(s): | .01; 20 mg/mL; mg/mL & nbsp; Lidocaine Hydrochloride and Epinephrine Bitartrate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lidocaine Hydrochloride and Epinephrine Bitartrate
| Product NDC: | 51004-2010 |
| Labeler Name: | Novocol Pharmaceutical of Canada, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088390 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111107 |
Package Information of Lidocaine Hydrochloride and Epinephrine Bitartrate
| Package NDC: | 51004-2010-5 |
| Package Description: | 50 CARTRIDGE in 1 CARTON (51004-2010-5) > 1.7 mL in 1 CARTRIDGE |
NDC Information of Lidocaine Hydrochloride and Epinephrine Bitartrate
| NDC Code | 51004-2010-5 |
| Proprietary Name | Lidocaine Hydrochloride and Epinephrine Bitartrate |
| Package Description | 50 CARTRIDGE in 1 CARTON (51004-2010-5) > 1.7 mL in 1 CARTRIDGE |
| Product NDC | 51004-2010 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lidocaine Hydrochloride and Epinephrine Bitartrate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20111107 |
| Marketing Category Name | ANDA |
| Labeler Name | Novocol Pharmaceutical of Canada, Inc. |
| Substance Name | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE |
| Strength Number | .01; 20 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |
